Complete Filing Data
Sagimet Biosciences Inc. reported Stockholders Equity of $111.38 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sagimet Biosciences Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | -$51.0M | -$45.6M | -$27.9M | -$30.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$110.0K | $200.0K | $114.0K | -$84.0K |
| Research And Development Expense | $39.1M | $38.4M | $19.8M | $24.9M |
| Operating Income Loss | -$56.9M | -$54.5M | -$30.7M | -$31.1M |
| Operating Expenses | $56.9M | $54.5M | $32.7M | $31.1M |
| General And Administrative Expense | $17.8M | $16.0M | $13.0M | $6.1M |
| Comprehensive Income Net Of Tax | -$51.1M | -$45.4M | -$27.8M | -$30.6M |
| Other Nonoperating Income Expense | $5.9M | $8.9M | $2.9M | $556.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $114.0K | -$84.0K | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$12.9M | -$10.4M | -$18.2M | -$14.6M | -$8.1M | -$6.6M | -$6.4M | -$6.8M | -$6.6M | -$7.5M | -$7.1M | -$8.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $41.0K | -$45.0K | -$109.0K | $464.0K | -$30.0K | -$23.0K | $13.0K | $71.0K | -$56.0K | -$106.0K | ||
| Research And Development Expense | $9.7M | $7.2M | $15.3M | $12.7M | $6.3M | $5.3M | $5.0M | $4.7M | $4.5M | $6.8M | $6.4M | |
| Operating Income Loss | -$14.3M | -$11.9M | -$19.9M | -$16.9M | -$10.6M | -$8.8M | -$7.5M | -$7.1M | -$6.8M | -$7.7M | -$7.2M | |
| Operating Expenses | $14.3M | $11.9M | $19.9M | $16.9M | $10.6M | $8.8M | $9.5M | $7.1M | $6.8M | $7.7M | $7.2M | |
| General And Administrative Expense | $4.6M | $4.7M | $4.5M | $4.2M | $4.3M | $3.5M | $4.5M | $2.4M | $2.3M | $848.0K | $867.0K | |
| Comprehensive Income Net Of Tax | -$12.9M | -$10.4M | -$18.3M | -$14.2M | -$8.1M | -$6.7M | -$6.4M | -$6.8M | -$6.5M | -$7.5M | -$7.2M | |
| Other Nonoperating Income Expense | $1.4M | $1.5M | $1.7M | $2.3M | $2.5M | $2.1M | $1.1M | $272.0K | $178.0K | $219.0K | $136.0K | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$23.0K | $13.0K | $71.0K | -$56.0K | -$106.0K | |||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $2.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $111.4M | $155.8M | $91.1M | -$187.0M | -$158.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $35.0M | $75.8M | $75.1M | $158.0K | $56.7M |
| Non Cash Operating Lease Expenses | $151.0K | $145.0K | $139.0K | $130.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$40.8M | $701.0K | |||
| Retained Earnings Accumulated Deficit | -$346.3M | -$295.3M | -$249.7M | -$221.9M | |
| Prepaid Expense And Other Assets Current | $3.3M | $1.5M | $1.7M | $447.0K | |
| Operating Lease Right Of Use Asset | $78.0K | $77.0K | $73.0K | $212.0K | |
| Operating Lease Liability Current | $78.0K | $78.0K | $65.0K | $133.0K | |
| Liabilities And Stockholders Equity | $116.5M | $160.3M | $96.7M | $33.0M | |
| Cash And Cash Equivalents At Carrying Value | $35.0M | $75.8M | $75.1M | $158.0K | |
| Assets Current | $116.4M | $152.8M | $96.6M | $32.8M | |
| Assets | $116.5M | $160.3M | $96.7M | $33.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $389.0K | $1.3M | $37.0K | $212.0K | |
| Accounts Payable Current | $1.3M | $1.4M | $186.0K | $1.1M | |
| Marketable Securities Current | $78.1M | $75.4M | $19.8M | $32.2M | |
| Accrued Liabilities Current | $3.7M | $3.0M | $5.4M | $4.0M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $120.0K | $230.0K | $30.0K | -$84.0K | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $152.0K | $149.0K | |||
| Liabilities Current | $5.1M | $4.5M | $5.7M | $5.3M | |
| Liabilities | $5.4M | ||||
| Marketable Securities Noncurrent | $0.00 | $7.4M | |||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $9.0K | $0.00 | $323.0K | ||
| Temporary Equity Carrying Amount Attributable To Parent | $214.6M | ||||
| Preferred Stock Value | $0.00 | $0.00 | |||
| Common Stock Value | $1.0K | ||||
| Temporary Equity Liquidation Preference | $233.0M | ||||
| Reclassifications Of Temporary To Permanent Equity | $214.6M | ||||
| Operating Lease Liability Noncurrent | $78.0K | ||||
| Deposits Assets Noncurrent | $27.0K | ||||
| Deferred Financing Costs Written Off | $230.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $119.3M | $130.2M | $139.0M | $170.7M | $183.3M | $190.0M | $97.9M | -$198.4M | -$192.7M | -$180.6M | -$173.4M | -$166.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.5M | $42.3M | $64.7M | $77.0M | $96.0M | $176.8M | $101.8M | $158.0K | $12.3M | $2.2M | $4.5M | |||
| Non Cash Operating Lease Expenses | $39.0K | $36.0K | $34.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $101.6M | $12.2M | ||||||||||||
| Retained Earnings Accumulated Deficit | -$336.8M | -$323.9M | -$313.5M | -$279.1M | -$264.5M | -$256.4M | -$241.6M | -$235.2M | ||||||
| Prepaid Expense And Other Assets Current | $2.8M | $1.8M | $1.5M | $4.7M | $378.0K | $786.0K | $974.0K | $2.8M | ||||||
| Operating Lease Right Of Use Asset | $115.0K | $152.0K | $38.0K | $114.0K | $151.0K | $37.0K | $109.0K | $144.0K | ||||||
| Operating Lease Liability Current | $115.0K | $152.0K | $39.0K | $116.0K | $153.0K | $26.0K | $103.0K | $140.0K | ||||||
| Liabilities And Stockholders Equity | $128.4M | $137.4M | $146.2M | $174.8M | $189.0M | $194.5M | $102.9M | $21.5M | ||||||
| Cash And Cash Equivalents At Carrying Value | $32.5M | $42.3M | $64.7M | $77.0M | $96.0M | $176.8M | $101.8M | $18.5M | ||||||
| Assets Current | $119.5M | $127.2M | $146.1M | $157.2M | $166.8M | $194.5M | $102.8M | $21.4M | ||||||
| Assets | $128.4M | $137.4M | $146.2M | $174.8M | $189.0M | $194.5M | $102.9M | $21.5M | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $535.0K | $193.0K | $35.0K | |||||||||||
| Accounts Payable Current | $4.2M | $1.9M | $3.2M | $1.2M | $2.0M | $531.0K | $1.7M | $2.7M | ||||||
| Marketable Securities Current | $84.2M | $83.1M | $79.9M | $75.5M | $70.4M | $16.9M | $0.00 | $0.00 | ||||||
| Accrued Liabilities Current | $4.8M | $5.2M | $3.9M | $2.8M | $3.6M | $4.0M | $3.2M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $117.0K | $76.0K | $121.0K | $441.0K | -$23.0K | $7.0K | ||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | ||||||||||||||
| Liabilities Current | $9.1M | $7.2M | $5.0M | $5.3M | ||||||||||
| Liabilities | $7.2M | $4.5M | $4.1M | $5.7M | $4.5M | $5.7M | $5.1M | $5.3M | ||||||
| Marketable Securities Noncurrent | $8.8M | $10.1M | $17.5M | $22.1M | ||||||||||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $245.0K | $1.2M | ||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $214.6M | |||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | ||||||||||||
| Common Stock Value | $1.0K | |||||||||||||
| Temporary Equity Liquidation Preference | $233.0M | |||||||||||||
| Reclassifications Of Temporary To Permanent Equity | $214.6M | |||||||||||||
| Operating Lease Liability Noncurrent | ||||||||||||||
| Deposits Assets Noncurrent | ||||||||||||||
| Deferred Financing Costs Written Off |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$45.7M | -$42.4M | -$23.8M | -$24.5M |
| Share Based Compensation | $6.4M | $5.3M | $5.0M | $1.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.8M | $5.0K | $952.0K | -$1.4M |
| Increase Decrease In Operating Lease Liability | -$152.0K | -$136.0K | -$146.0K | -$137.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $929.0K | -$907.0K | $120.0K | $2.9M |
| Net Cash Provided By Used In Investing Activities | $4.6M | -$61.7M | $12.6M | -$32.0M |
| Net Cash Provided By Used In Financing Activities | $275.0K | $104.8M | $86.2M | -$73.0K |
| Proceeds From Stock Options Exercised | $275.0K | $114.0K | $6.0K | $12.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $111.4M | $46.4M | $32.2M | $9.4M |
| Payments Of Financing Costs | $0.00 | $1.0M | $3.5M | $85.0K |
| Payments To Acquire Marketable Securities | $106.9M | $108.1M | $19.6M | $41.4M |
| Proceeds From Issuance Of Common Stock | $0.00 | $105.8M | ||
| Payments Of Stock Issuance Costs | $7.8M | $10.3M | ||
| Stock Issued During Period Value Share Based Compensation | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q1 2024 | Q3 2023 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$14.5M | -$6.2M | -$7.1M | -$10.8M | ||
| Share Based Compensation | $1.5M | $759.0K | $767.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $687.0K | -$640.0K | $37.0K | |||
| Increase Decrease In Operating Lease Liability | -$39.0K | -$39.0K | -$35.0K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.4M | -$782.0K | -$1.2M | |||
| Net Cash Provided By Used In Investing Activities | $3.4M | $3.0M | $19.4M | |||
| Net Cash Provided By Used In Financing Activities | $104.8M | -$136.0K | ||||
| Proceeds From Stock Options Exercised | $114.0K | $0.00 | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $19.0M | $3.0M | $19.4M | |||
| Payments Of Financing Costs | $1.0M | $136.0K | ||||
| Payments To Acquire Marketable Securities | $15.6M | |||||
| Proceeds From Issuance Of Common Stock | $105.8M | |||||
| Payments Of Stock Issuance Costs | $7.8M | $10.3M | ||||
| Stock Issued During Period Value Share Based Compensation | $1.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 32.3M | 31.4M | 10.5M | 184.6K |
| Earnings Per Share Diluted | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
| Weighted Average Number Of Shares Outstanding Basic | 32.3M | 31.4M | 10.5M | 184.6K |
| Earnings Per Share Basic | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | |||
| Common Stock Shares Authorized | 0.00 | 1.61B | ||
| Temporary Equity Shares Outstanding | 0.00 | 1.37B | ||
| Temporary Equity Shares Issued | 0.00 | 1.37B | ||
| Temporary Equity Shares Authorized | 0.00 | 1.37B | ||
| Common Stock Shares Issued | 0.00 | 185.1K | ||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 0.00 | 185.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 32.5M | 32.2M | 32.2M | 32.1M | 31.9M | 29.0M | 18.2M | 189.5K | 185.1K | 185.1K | 185.1K | |
| Earnings Per Share Diluted | $-0.40 | $-0.32 | $-0.56 | $-0.45 | $-0.25 | $-0.23 | $-0.35 | $-35.80 | $-35.58 | $-40.34 | $-38.37 | |
| Weighted Average Number Of Shares Outstanding Basic | 32.5M | 32.2M | 32.2M | 32.1M | 31.9M | 29.0M | 18.2M | 189.5K | 185.1K | 185.1K | 185.1K | |
| Earnings Per Share Basic | $-0.40 | $-0.32 | $-0.56 | $-0.45 | $-0.25 | $-0.23 | $-0.35 | $-35.80 | $-35.58 | $-40.34 | $-38.37 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Authorized | 0.00 | 1.64B | 1.61B | |||||||||
| Temporary Equity Shares Outstanding | 0.00 | 1.37B | ||||||||||
| Temporary Equity Shares Issued | 0.00 | 1.37B | ||||||||||
| Temporary Equity Shares Authorized | 0.00 | 1.37B | ||||||||||
| Common Stock Shares Issued | 0.00 | 210.3K | ||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | |||||||||||
| Common Stock Shares Outstanding | 0.00 | 210.3K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.4M | $5.3M | $5.0M | $1.9M |
| Interest And Other Income | $5.9M | $8.9M | $2.9M | $553.0K |
| Additional Paid In Capital | $457.6M | $450.9M | $340.8M | $35.0M |
| Stock Issued During Period Value Stock Options Exercised | $275.0K | $114.0K | $6.0K | $12.0K |
| Stock Issued During Period Value New Issues | $104.7M | $86.2M | ||
| Stock Issued During Period Shares Stock Options Exercised | 18.0K | 7.6K | ||
| Fair Value Adjustment Of Warrants | -$4.0K | -$3.0K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | ||||
| Warrants And Rights Outstanding | $4.0K | |||
| Sale Of Stock Consideration Received On Transaction | $89.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.7M | $1.6M | $1.5M | $1.5M | $1.4M | $759.0K | $1.9M | $1.1M | $767.0K | $389.0K | $383.0K | $387.0K |
| Interest And Other Income | $1.4M | $1.5M | $1.7M | $2.3M | $2.5M | $2.1M | $1.1M | $272.0K | $180.0K | $218.0K | $136.0K | |
| Additional Paid In Capital | $455.9M | $454.0M | $452.4M | $449.3M | $447.8M | $446.4M | $339.5M | $36.8M | ||||
| Stock Issued During Period Value Stock Options Exercised | $274.0K | $114.0K | $6.0K | $12.0K | ||||||||
| Stock Issued During Period Value New Issues | $104.7M | $86.2M | ||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 18.0K | |||||||||||
| Fair Value Adjustment Of Warrants | -$1.0K | $2.0K | ||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $27.0K | |||||||||||
| Warrants And Rights Outstanding | ||||||||||||
| Sale Of Stock Consideration Received On Transaction |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.